Iishi H, Tatsuta M, Baba M, Yamamoto R, Taniguchi H
Department of Gastrointestinal Oncology, Center for Adult Diseases, Osaka, Japan.
Br J Cancer. 1993 Sep;68(3):515-8. doi: 10.1038/bjc.1993.378.
The affects of L-thyroxine (T4) on the incidence and histology of gastric cancers induced by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), and on the labelling index of gastric mucosal epithelial cells were investigated in Wistar rats. After oral treatment with MNNG for 25 weeks, the rats received s.c. injections of T4 (0.2 microgram kg-1) in depot form every other day until the end of the experiment in Week 52. This long-term treatment with T4 significantly increased the incidence of gastric cancers in Week 52. However, it did not influence the histological type of the gastric cancers. It also caused significant increases in the labelling indices of the fundic and antral epithelial cells. These findings indicate that T4 enhances the development of gastric cancers, and that its effect may be related to its effect in increasing proliferation of gastric epithelial cells.
在Wistar大鼠中研究了L-甲状腺素(T4)对N-甲基-N'-硝基-N-亚硝基胍(MNNG)诱导的胃癌发生率和组织学的影响,以及对胃黏膜上皮细胞标记指数的影响。在用MNNG口服治疗25周后,大鼠每隔一天接受皮下注射长效形式的T4(0.2微克/千克),直至第52周实验结束。T4的这种长期治疗显著增加了第52周时胃癌的发生率。然而,它并不影响胃癌的组织学类型。它还导致胃底和胃窦上皮细胞的标记指数显著增加。这些发现表明,T4促进胃癌的发展,其作用可能与其增加胃上皮细胞增殖的作用有关。